A noncomparative randomized phase II study of two dose levels of itraconazole in men with metastatic castration-resistant prostate cancer (mCRPC): A DOD/PCCTC trial.
Authors:
- E. S. AntonarakisEAE. S. Antonarakis
- E. I. HeathEHE. I. Heath
- D. C. SmithDSD. C. Smith
- D. E. RathkopfDRD. E. Rathkopf
- A. L. BlackfordABA. L. Blackford
- D. C. DanilaDDD. C. Danila
- S. KingSKS. King
- A. FrostAFA. Frost
- M. A. CarducciMCM. A. Carducci
- Prostate Cancer Clinical Trials Consortium (PCCTC)P(Prostate Cancer Clinical Trials Consortium (PCCTC)
- 20 May 2011
- journal article
- genitourinary cancer
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 29 (15) , 4532